Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
- Status
- TERMINATED
- Phase
- NA
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Trial of LCL161 and Gemcitabine Plus Nab-Paclitaxel in Metastatic Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Chemoimmunotherapy and Radiation in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
- Status
- COMPLETED
- Phase
- PHASE2